Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay.

Magooa MP, Müller EE, Gumede L, Lewis DA.

Int J Antimicrob Agents. 2013 Jul;42(1):63-7. doi: 10.1016/j.ijantimicag.2013.02.026. Epub 2013 Apr 24.

PMID:
23623337
2.

Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples.

Siedner MJ, Pandori M, Castro L, Barry P, Whittington WL, Liska S, Klausner JD.

J Clin Microbiol. 2007 Apr;45(4):1250-4. Epub 2007 Jan 31.

4.

Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies.

Giles JA, Falconio J, Yuenger JD, Zenilman JM, Dan M, Bash MC.

J Infect Dis. 2004 Jun 1;189(11):2085-93. Epub 2004 Apr 30.

PMID:
15143477
5.

Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology.

Zhou W, Du W, Cao H, Zhao J, Yang S, Li W, Shen Y, Zhang S, Du W, Zhang X.

J Clin Microbiol. 2004 Dec;42(12):5819-24.

6.

A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility.

Buckley C, Trembizki E, Donovan B, Chen M, Freeman K, Guy R, Kundu R, Lahra MM, Regan DG, Smith H, Whiley DM; GRAND Study Investigators.

J Antimicrob Chemother. 2016 Feb;71(2):353-6. doi: 10.1093/jac/dkv366. Epub 2015 Nov 3.

PMID:
26538505
7.

Trend of ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Italy and analysis of the molecular determinants.

Starnino S, Dal Conte I, Matteelli A, Galluppi E, Cusini M, Di Carlo A, Delmonte S, Stefanelli P.

Diagn Microbiol Infect Dis. 2010 Aug;67(4):350-4. doi: 10.1016/j.diagmicrobio.2010.03.001.

PMID:
20638603
8.

Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.

Shigemura K, Shirakawa T, Okada H, Hinata N, Acharya B, Kinoshita S, Kofuku T, Kawabata M, Kamidono S, Arakawa S, Gotoh A.

Sex Transm Dis. 2004 Mar;31(3):180-4.

PMID:
15076932
9.

Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.

Tanaka M, Takahashi K, Saika T, Kobayashi I, Ueno T, Kumazawa J.

J Urol. 1998 Jun;159(6):2215-9.

PMID:
9598572
10.

Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.

Shigemura K, Shirakawa T, Okada H, Tanaka K, Udaka T, Kamidono S, Arakawa S, Gotoh A.

J Microbiol Methods. 2004 Dec;59(3):415-21.

PMID:
15488283
11.

Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.

Yang Y, Liao M, Gu WM, Bell K, Wu L, Eng NF, Zhang CG, Chen Y, Jolly AM, Dillon JA.

J Antimicrob Chemother. 2006 Oct;58(4):868-72. Epub 2006 Jul 30.

PMID:
16880174
12.

Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.

Ng LK, Sawatzky P, Martin IE, Booth S.

Sex Transm Dis. 2002 Dec;29(12):780-8.

PMID:
12466720
13.

Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India.

Kulkarni S, Bala M, Sane S, Pandey S, Bhattacharya J, Risbud A.

Int J Antimicrob Agents. 2012 Dec;40(6):549-53. doi: 10.1016/j.ijantimicag.2012.08.007. Epub 2012 Oct 11.

PMID:
23063097
14.

Fluoroquinolone resistance among Neisseria gonorrhoeae isolates from Shanghai, China: detection of quinolone resistance-determining region mutations.

Tiejun Z, Xiaoming Z, Jilun Z, Yinghu Z, Yanhua R, Yue C, Weiming G, Tao Z, Qingwu J.

Indian J Med Res. 2009 Jun;129(6):701-6.

PMID:
19692753
15.

Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.

Uehara AA, Amorin EL, Ferreira Mde F, Andrade CF, Clementino MB, de Filippis I, Neves FP, Pinto Tde C, Teixeira LM, Giambiagi-Demarval M, Fracalanzza SE.

J Clin Microbiol. 2011 Dec;49(12):4208-12. doi: 10.1128/JCM.01175-11. Epub 2011 Oct 5.

16.

Genotyping of two Neisseria gonorrhoeae fluroquinolone-resistant strains in the Brazilian Amazon Region.

Ferreira WA, Ferreira CM, Naveca FG, Almeida NC, Vasconcelos Wde S, Gomes Jde S, Silva Mde F, Alecrim Md.

Mem Inst Oswaldo Cruz. 2011 Aug;106(5):629-31.

17.

Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae.

Hemarajata P, Yang S, Soge OO, Humphries RM, Klausner JD.

J Clin Microbiol. 2016 Mar;54(3):805-8. doi: 10.1128/JCM.03032-15. Epub 2016 Jan 6.

18.

[Study on fluoroquinolone resistance and the relationship between resistance and mutations of gyrA and parC in Neisseria gonorrhoeae].

Xu JS, Wang B, Wang CX, Gou HJ, Mi ZH, Ling JH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Aug;27(8):702-4. Chinese.

PMID:
17172112
20.

Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain.

Goire N, Ohnishi M, Limnios AE, Lahra MM, Lambert SB, Nimmo GR, Nissen MD, Sloots TP, Whiley DM.

J Antimicrob Chemother. 2012 Apr;67(4):902-5. doi: 10.1093/jac/dkr549. Epub 2011 Dec 29.

PMID:
22207596

Supplemental Content

Support Center